BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Janus Pharmaceuticals, Inc. Announces Successful Phase II Study In Shingles


12/4/2006 12:33:34 PM

LOS ANGELES--(BUSINESS WIRE)--Janus Pharmaceuticals Inc. (Janus), a company focused on the discovery and development of drugs to treat a variety of topical diseases, today announced positive results of its ARYS-0502 study of topical ARYS-01 Cream for the treatment of patients with primary Herpes Zoster (Shingles) episodes. "We are greatly excited about these results,” Dr. Norifumi Nakamura, CEO of Janus, announced. “Despite the fact that this was an under-powered study for efficacy, and the first time an agent with this mechanism of action has been evaluated in this population of patients, these data do show remarkably consistent improvements in all the clinical and surrogate markers in all efficacy parameters that suggests topical ARYS-01 Cream can alter the pathophysiology of Herpes Zoster."

Read at BioSpace.com

   
Shingles

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES